Variant type and patient sex affect molnupiravir efficacy, study finds
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study.
Read Original Article: Variant type and patient sex affect molnupiravir efficacy, study finds »
